Parallel synthesis of 2-Aryl-4-aminobenzimidazoles and their evaluation as gonadotropin releasing hormone antagonists

Journal of Combinatorial Chemistry

Volumn 11, Issue 1, 2009, Pages 117-125

  Green, Daniel M ^a   Goljer, Igor ^a   Andraka, Diane S ^a   Chengalvala, Murty ^a   Shanno, Linda ^a   Hurlburt, Warren ^a   Pelletier, Jeffrey C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CARBOXYLIC ACID; DIAMINE; GONADORELIN; HORMONE ANTAGONIST;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; IC 50; MOLECULAR LIBRARY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

BENZIMIDAZOLES; CARBOXYLIC ACIDS; COMBINATORIAL CHEMISTRY TECHNIQUES; DIAMINES; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; INHIBITORY CONCENTRATION 50; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 60849135129     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc800106h     Document Type: Article

References (28)

1. Matsuo, H.; Baba, Y.; Nair, R. M. G.; Arimura, A.; Schally, A. V. Biochem. Biophys. Res. Commun. 1971, 43, 1334-1339.
2. (a) Schally, A. V.; Arimura, A.; Kastin, A. J.; Matsuo, H.; Baba, Y.; Redding, T. W.; Nair, R. M. G.; Debeljuk, L. Science 1971, 173, 1036-1038.
3. (b) Millar, R. P.; Lu, Z.-L.; Pawson, A. J.; Flanagan, C. A.; Morgan, K.; Maudsley, S. R. Endocr. Rev. 2004, 25, 235-275.
4. (a) Chengalvala, M. V.; Pelletier, J. C.; Kopf, G. S. Curr. Med. Chem. Anti-Cancer Agents 2003, 3, 399-410.
5. (b) Moreau, J.-P.; Delavault, P.; Blumberg, J. Clin. Ther. 2006, 28, 1485-1508.
6. Betz, S. F.; Zhu, Y.-F.; Chen, C.; Struthers, R. S. J. Med. Chem. 2008, 51, 3331-3348.
7. Pelletier, J. C.; Chengalvala, M.; Cottom, J.; Feingold, I.; Garrick, L.; Green, D.; Hauze, D.; Husleton, C.; Jetter, J.; Kao, W.; Kopf, G. S.; Lundquist, J. T.; Mann, C.; Mehlmann, J.; Rogers, J.; Shanno, L.; Wrobel, J. Bioorg. Med. Chem. 2008, 16, 6617-6640.
8. (a) Preston, P. N. In The Chemistry of Heterocyclic Compounds, Benzimidazoles and Congeneric Tricyclic Compounds; John Wiley & Son: New York, 1980; Vol. 40,Part 2; Chapter 10; According to Evans, a privileged structure is 'a single molecular framework able to provide ligands for diverse receptors', see: .
9. (b) Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.; Kling, P. J.; Kunkel, K. A.; Springer, J. P.; Hirshfield, J. J. Med. Chem. 1988, 31, 2235.
10. (a) Navarrete-Vazquez, G.; Cedillo, R.; Hernandex-Campos, A.; Yepez, L.; Hernandez-Luis, F.; Valdez, J.; Morales, R.; Cortes, R.; Hernandez, M.; Castillo, R. Bioorg. Med. Chem. Lett. 2001, 11. 187-190.
11. (b) Kucukbay, H.; Durmaz, R.; Guven, M.; Gunal, S. Arzneim.-Forsch. 2001, 51, 402-42A.
12. (c) Zarrin Mayeh, A.; Zimmerman, D. M.; Cantrell, B. E.; Schober, D. A.; Burns, R. B.; Gackenheimer, S. L.; Ornstein, P. L.; Hipskind, P. A.; Britten, T. C.; Gchiert, D. R. Bioorg. Med. Chem. Lett. 1999, 9, 647-652.
13. Spasov, A. A.; Yozhitsa, I. N.; Bugaeva, L. I.; Anisimova, V. A. Pharm. Chem. J. 1999, 33, 232-243.
14. Liu, J.-F.; Lin, S.-Y.; Isome, Y.; Stewart, E.; Yohannes, D.; Yu, L. Tetrahedron Lett. 2006, 47, 2883-2886, and references cited therein.
15. Bendale, P. M.; Sun, C.-M. J. Comb. Chem. 2002, 4, 359-361, and references cited therein.
16. (a) Liu, G.; Li, L.; Wang, Z.; Yuan, Y.; Zhang, C.; Tian, H.; Wu, X.; Zhang, J. J. Comb. Chem. 2004, 6, 811-821.
17. (b) Tumelty, D.; Cao, K.; Holmes, C. P. Org. Lett. 2001, 3, 83-86.
18. (c) Mazurov, A. Bioorg. Med. Chem. Lett. 2000, 10, 67-70.
19. (d) Sun, Q.; Yan, B. Bioorg. Med. Chem, Lett. 1998, 8, 361-362.
20. (e) Smith, J. M.; Gard, J.; Cummings, W.; Kanizsai, A.; Krchnak, V. J. Comb. Chem. 1999, 1, 368-370.
21. (f) Smith, J. M.; Krchnak, V. Tetrahedron Lett. 1999, 40, 7633-7636.
22. (g) Thomas, J. B.; Fall, M. J.; Cooper, J. B.; Burgess, J. P.; Carroll, F. I. Tetrahedron Lett. 1997, 38, 5099-5102.
23. (h) Vourloumis, D.; Takahashi, M.; Simonsen, K. B.; Ayida, B. K.; Barluenga, S.; Winters, G. C.; Hermann, T. Tetrahedron Lett. 2003, 44, 2807-2811.
24. (a) Thompson, L. A. Curr. Opin. Chem. Biol. 2000, 4, 324. (b) Flynn, D. L. Med. Res. Rev. 1999, 19, 408.
25. Millar, R. P.; Davidson, J.; Flanagan, C.; Wakefield, I. Methods Neurosci. 1995, 25, 145-162.
26. Rowbottom, M. W.; Tucci, F.C. Jr.; Gross, T. D.; Zhu, Y.-F.; Guo, Z.; Moorjani, M.; Acevedo, O.; Carter, L.; Sullivan, S. K.; Xie, Q.; Fisher, A.; Struthers, R. S.; Saunders, J.; Chen, C. Bioorg. Med. Chem. Lett. 2004, 14, 4967-4973.
27. 50 values of matched compounds to claim bioequivalence. A further explanation showing additional compounds can be found in ref 5.
28. Smallcombe, S. H.; Patt, S. L.; Keifer, P. A. J. Magn. Reson. 1995, 117, 295-303.